
Denmark · Genetics startup
Alvara Therapeutics develops small-molecule therapies for chronic kidney disease.
Funding reportedLast round: Pre-Seed
Funding, as reported
Add your raise, your deck and your story, and put Alvara Therapeutics in front of investors. Or tell us what we have wrong.